The inability of the protein encoded by the D2-CD33 mRNAs to bind sialic acids and suppress microglia, resulting in increased phagocytic capacity of amyloid plaques, is one mechanism proposed by which the causal rs12459419 SNP modifies AD risk. This evidence concerns the gene CD33 and Alzheimer disease.